Benjamin Mullin

Dr Benjamin Mullin is a Research Fellow at the School of Biomedical Sciences, University of Western Australia, leading the osteoclast unit in the Molecular Endocrinology laboratory at QEII Medical Centre. He holds a PhD in genetic epidemiology of osteoporosis (Curtin University, 2011) and has extensive experience in medical genetics research.

Research interests focus on genetics of complex diseases, particularly skeletal disorders and reproductive endocrinology. Key contributions include pioneering genome-wide association studies (GWAS) for osteoporosis and bone structural traits, leading international meta-analyses, and developing osteoclast-specific eQTL resources.

Publications span top-tier journals like The Lancet, Nature Genetics, and Journal of Bone and Mineral Research. Awards include a Raine Medical Research Foundation Fellowship. Active in grant leadership, including NHMRC Ideas Grants, and serves as a peer reviewer for major journals.

Grants: Chief Investigator on NHMRC-funded projects including 'Unlocking the Therapeutic Potential of a New ‘Dual-Action’ Target for Bone and Joint Diseases' (2023–2026). Co-inventor on four provisional patents and involved in collaborative research networks globally.

Labs/Teams: Leads osteoclast unit at QEII Medical Centre and collaborates with GEFOS Consortium for osteoporosis research.